The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in children

Introduction. Colonization of the skin with S. aureus and S. epidermidis in children with atopic dermatitis leads to the initiation of inflammation and worsening of the disease. The control of overcolonization with S. aureus is an important issue in pediatric dermatological practice. At the same tim...

Full description

Bibliographic Details
Main Authors: O. V. Zhukova, E. I. Kasikhina, M. N. Ostretsova, G. P. Tereshchenko, A. M. Nemer
Format: Article
Language:Russian
Published: Remedium Group LLC 2022-03-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6745
_version_ 1797841923712483328
author O. V. Zhukova
E. I. Kasikhina
M. N. Ostretsova
G. P. Tereshchenko
A. M. Nemer
author_facet O. V. Zhukova
E. I. Kasikhina
M. N. Ostretsova
G. P. Tereshchenko
A. M. Nemer
author_sort O. V. Zhukova
collection DOAJ
description Introduction. Colonization of the skin with S. aureus and S. epidermidis in children with atopic dermatitis leads to the initiation of inflammation and worsening of the disease. The control of overcolonization with S. aureus is an important issue in pediatric dermatological practice. At the same time, to achieve a controlled level of colonization, it is preferable to prescribe non-steroidal external agents. Activated zinc pyrithione has a wide range of complementary pharmacodynamic effects, including anti-inflammatory, pro-apoptogenic, antimicrobial, and antifungal. The article presents the results of the use of zinc pyrithione in mild IgE-independent atopic dermatitis in children. The results of the main clinical studies confirming the effect of zinc pyrithione on the microbiome in AD and the severity of the disease were analyzed.Aim. To evaluate the therapeutic and microbiological efficacy of activated zinc pyrithione as monotherapy in patients with IgEindependent atopic dermatitis.Materials and methods. 30 patients aged 2 to 8 years with mild atopic dermatitis in the acute stage were divided into 2 groups. Group 1 received activated zinc pyrithione, group 2 received a combined topical steroid.Results. Both groups showed a significant reduction in S. aureus skin colonization. In both groups, in comparison with the initial state, a significant decrease in the severity of clinical manifestations of AD was obtained. The therapeutic efficacy of zinc pyrithione was 93.3%, clinical remission was observed in 73.3% of cases.Conclusion. The totality of currently available data on the clinical efficacy and safety of activated zinc pyrithione allows us to recommend it as one of the effective agents for external therapy of mild IgE-independent atopic dermatitis. The use of activated zinc pyrithione showed a rapid, pronounced positive result of treatment, a decrease in the risk of secondary infection in observed children with IgE-independent atopic dermatitis.
first_indexed 2024-04-09T16:39:22Z
format Article
id doaj.art-b465cbb1966f424ca28103c85e9bcf75
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:39:22Z
publishDate 2022-03-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-b465cbb1966f424ca28103c85e9bcf752023-04-23T06:56:45ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902022-03-0103889410.21518/2079-701X-2022-16-3-88-946065The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in childrenO. V. Zhukova0E. I. Kasikhina1M. N. Ostretsova2G. P. Tereshchenko3A. M. Nemer4Peoples’ Friendship University of Russia; Moscow Scientific and Practical Center of Dermatovenereology and CosmetologyPeoples’ Friendship University of Russia; Moscow Scientific and Practical Center of Dermatovenereology and CosmetologyPeoples’ Friendship University of RussiaPeoples’ Friendship University of Russia; Moscow Scientific and Practical Center of Dermatovenereology and CosmetologyPeoples’ Friendship University of RussiaIntroduction. Colonization of the skin with S. aureus and S. epidermidis in children with atopic dermatitis leads to the initiation of inflammation and worsening of the disease. The control of overcolonization with S. aureus is an important issue in pediatric dermatological practice. At the same time, to achieve a controlled level of colonization, it is preferable to prescribe non-steroidal external agents. Activated zinc pyrithione has a wide range of complementary pharmacodynamic effects, including anti-inflammatory, pro-apoptogenic, antimicrobial, and antifungal. The article presents the results of the use of zinc pyrithione in mild IgE-independent atopic dermatitis in children. The results of the main clinical studies confirming the effect of zinc pyrithione on the microbiome in AD and the severity of the disease were analyzed.Aim. To evaluate the therapeutic and microbiological efficacy of activated zinc pyrithione as monotherapy in patients with IgEindependent atopic dermatitis.Materials and methods. 30 patients aged 2 to 8 years with mild atopic dermatitis in the acute stage were divided into 2 groups. Group 1 received activated zinc pyrithione, group 2 received a combined topical steroid.Results. Both groups showed a significant reduction in S. aureus skin colonization. In both groups, in comparison with the initial state, a significant decrease in the severity of clinical manifestations of AD was obtained. The therapeutic efficacy of zinc pyrithione was 93.3%, clinical remission was observed in 73.3% of cases.Conclusion. The totality of currently available data on the clinical efficacy and safety of activated zinc pyrithione allows us to recommend it as one of the effective agents for external therapy of mild IgE-independent atopic dermatitis. The use of activated zinc pyrithione showed a rapid, pronounced positive result of treatment, a decrease in the risk of secondary infection in observed children with IgE-independent atopic dermatitis.https://www.med-sovet.pro/jour/article/view/6745s. аureusactivated zinc pyrithioneige-independent atopic dermatitischildhoodexternal therapy
spellingShingle O. V. Zhukova
E. I. Kasikhina
M. N. Ostretsova
G. P. Tereshchenko
A. M. Nemer
The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in children
Медицинский совет
s. аureus
activated zinc pyrithione
ige-independent atopic dermatitis
childhood
external therapy
title The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in children
title_full The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in children
title_fullStr The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in children
title_full_unstemmed The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in children
title_short The efficacy of activated zinc pyrithione in the treatment of IgE-independent atopic dermatitis in children
title_sort efficacy of activated zinc pyrithione in the treatment of ige independent atopic dermatitis in children
topic s. аureus
activated zinc pyrithione
ige-independent atopic dermatitis
childhood
external therapy
url https://www.med-sovet.pro/jour/article/view/6745
work_keys_str_mv AT ovzhukova theefficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT eikasikhina theefficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT mnostretsova theefficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT gptereshchenko theefficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT amnemer theefficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT ovzhukova efficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT eikasikhina efficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT mnostretsova efficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT gptereshchenko efficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren
AT amnemer efficacyofactivatedzincpyrithioneinthetreatmentofigeindependentatopicdermatitisinchildren